Search company, investor...
Search

Predict your next investment

Angel Investor (Individual)

See what CB Insights has to offer

Investments

1

About Gus Kenworthy

Gus Kenworthy Headquarters Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Gus Kenworthy News

Jamie Lynn Spears, Kate Gosselin Return to TV in Fox’s Celeb Competition Show ‘Special Forces: The Ultimate Test’

Sep 8, 2022

Jamie Lynn Spears and Kate Gosselin are making their return to tv with Fox’s star-studded actuality competitors sequence “Special Forces: The Ultimate Test” (working title), which is able to debut in January. Among the 16 recruits are Danny Amendola, Mel B, Hannah Brown, Tyler Florence, Dwight Howard, Montell Jordan, Gus Kenworthy, Nastia Liukin, Carli Lloyd, […] The post Jamie Lynn Spears, Kate Gosselin Return to TV in Fox’s Celeb Competition Show ‘Special Forces: The Ultimate Test’ appeared first on Pehal News.

Gus Kenworthy Investments

1 Investments

Gus Kenworthy has made 1 investments. Their latest investment was in Previse as part of their Angel on September 9, 2019.

CBI Logo

Gus Kenworthy Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/25/2019

Angel

Previse

Yes

2

Date

9/25/2019

Round

Angel

Company

Previse

Amount

New?

Yes

Co-Investors

Sources

2

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.